Pulike Biological Engineering Inc
SSE:603566
Pulike Biological Engineering Inc
Accounts Payable
Pulike Biological Engineering Inc
Accounts Payable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
Pulike Biological Engineering Inc
SSE:603566
|
Accounts Payable
¥103.9m
|
CAGR 3-Years
34%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Accounts Payable
¥217.9m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Accounts Payable
¥413m
|
CAGR 3-Years
18%
|
CAGR 5-Years
10%
|
CAGR 10-Years
17%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Accounts Payable
¥1.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
15%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Accounts Payable
¥4.6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
8%
|
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Accounts Payable
¥332.2m
|
CAGR 3-Years
71%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
Pulike Biological Engineering Inc
Glance View
Pulike Biological Engineering, Inc. engages in the research, development, manufacturing and sale of biological products for animals, chemical drugs and Chinese veterinary drugs. The company is headquartered in Luoyang, Henan and currently employs 1,809 full-time employees. The company went IPO on 2015-05-18. Inc is principally engaged in the research, development, production and distribution of veterinary biological products and chemical medicines. The firm's veterinary biological products include vaccine and antibody, applied in the prevention and controlling of infection to epidemic disease for poultry and livestock. Its veterinary chemical medicines are mainly used in the treatment of epidemic diseases of poultry and livestock.
See Also
What is Pulike Biological Engineering Inc's Accounts Payable?
Accounts Payable
103.9m
CNY
Based on the financial report for Sep 30, 2024, Pulike Biological Engineering Inc's Accounts Payable amounts to 103.9m CNY.
What is Pulike Biological Engineering Inc's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
31%
Over the last year, the Accounts Payable growth was 1%. The average annual Accounts Payable growth rates for Pulike Biological Engineering Inc have been 34% over the past three years , 31% over the past five years .
You don't have any saved screeners yet